07-06-2026 22:15 via medpagetoday.com

Add-On Orforglipron: Good News for Type 2 Diabetes and Inadequate Glycemic Control

(MedPage Today) -- NEW ORLEANS--Once-daily orforglipron (Foundayo) improved outcomes in adults with type 2 diabetes and inadequate glycemic control, the international ACHIEVE-5 trial showed.
In patients already taking background insulin glargine...
Read more »

Medical Industry news



'Bariatric Surgery-Level' Weight Loss With Novel Triple-Agonist
Up to 40% of Diabetes Patients Achieved Normal HbA1c With Retatrutide
'We're Close to Beer Time Here': What We Heard This Week
Late-Breaking Studies at EULAR Paint Rosy Picture of Rheumatology's Future
Modest Weight Loss Plus Few GI Upsets With Amylin Injectable
Can AI Save the Primary Care Exam Room From Quality Creep?
Post-Marketing Studies Document Extra VTE Risk for Baricitinib
Cancer Diagnosis Delays During Screening Study; Benefits of Resistance Training
The Case Against Calling It 'Emergency Medicine'
From Festering Infections to Untreated Cancer, ICE Detainees Report Medical Neglect
CDC Sees 10,000 Ebola Deaths Among Possible Outbreak Scenarios
One Surgical Technique for Cervical Lesions May Reduce Recurrences
Senator Cassidy Calls Out RFK Jr.
Finerenone Also Slows Kidney Decline in Diabetes-Free Patients
Desktop versie